SE8305535L - Lekemedelspreparat med antinikotinverkan och forfarande for framstellning derav - Google Patents
Lekemedelspreparat med antinikotinverkan och forfarande for framstellning deravInfo
- Publication number
- SE8305535L SE8305535L SE8305535A SE8305535A SE8305535L SE 8305535 L SE8305535 L SE 8305535L SE 8305535 A SE8305535 A SE 8305535A SE 8305535 A SE8305535 A SE 8305535A SE 8305535 L SE8305535 L SE 8305535L
- Authority
- SE
- Sweden
- Prior art keywords
- action
- pharmaceutical preparation
- polymeric vehicle
- antinicotic
- procedures
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/16—Two dimensionally sectional layer
- Y10T428/163—Next to unitary web or sheet of equal or greater extent
- Y10T428/164—Continuous two dimensionally sectional layer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/24—Structurally defined web or sheet [e.g., overall dimension, etc.]
- Y10T428/24802—Discontinuous or differential coating, impregnation or bond [e.g., artwork, printing, retouched photograph, etc.]
- Y10T428/2481—Discontinuous or differential coating, impregnation or bond [e.g., artwork, printing, retouched photograph, etc.] including layer of mechanically interengaged strands, strand-portions or strand-like strips
- Y10T428/24818—Knitted, with particular or differential bond sites or intersections
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU3425002 | 1982-02-22 | ||
SU3425001 | 1982-03-16 | ||
SU3470509 | 1982-06-07 |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8305535D0 SE8305535D0 (sv) | 1983-10-07 |
SE8305535L true SE8305535L (sv) | 1983-10-07 |
SE456135B SE456135B (sv) | 1988-09-12 |
Family
ID=27356396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8305535A SE456135B (sv) | 1982-02-22 | 1983-10-07 | Lekemedelspreparat med antinikotinverkan och forfarande for framstellning derav |
Country Status (7)
Country | Link |
---|---|
US (1) | US4971079A (sv) |
JP (1) | JPS59500217A (sv) |
CH (1) | CH658594A5 (sv) |
DE (1) | DE3332429T1 (sv) |
GB (1) | GB2125699B (sv) |
SE (1) | SE456135B (sv) |
WO (1) | WO1983002892A1 (sv) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8317576D0 (en) * | 1983-06-29 | 1983-08-03 | Shaw A S W | Consumer tobacco products |
JO1560B1 (en) * | 1989-01-21 | 1991-11-27 | الشركة العربية لصناعة الأدوية المساهمة المحدودة | Mouthwash to prevent smoking |
US5488962A (en) * | 1990-10-10 | 1996-02-06 | Perfetti, S.P.A. | Chewing gum which is a substitute for tobacco smoke |
AU9138891A (en) * | 1990-12-14 | 1992-07-08 | Steven J. Mondre | Nicotine-containing dental floss |
US5414005A (en) * | 1993-10-28 | 1995-05-09 | Dynagen, Inc. | Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation |
US5780051A (en) * | 1992-04-02 | 1998-07-14 | Dynagen, Inc. | Methods and articles of manufacture for nicotine cessation and monitoring nicotine use |
TW261531B (sv) * | 1993-10-28 | 1995-11-01 | Dynagen Inc | |
US5666979A (en) * | 1994-09-29 | 1997-09-16 | Chase; Gene | Cigar substitute |
US5875786A (en) * | 1994-09-29 | 1999-03-02 | Chase; Gene | Cigar substitute |
US5662919A (en) * | 1994-11-21 | 1997-09-02 | Alcon Laboratories, Inc. | Sulfated polyvinyl alcohol polymers to stabilize pharmaceutical drug compounds |
EP0937077B1 (en) | 1996-10-30 | 2006-05-17 | Pfizer Inc. | Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy |
US6949264B1 (en) | 1996-11-27 | 2005-09-27 | Wm. Wrigley Jr. Company | Nutraceuticals or nutritional supplements and method of making |
US6087376A (en) * | 1997-02-05 | 2000-07-11 | University Of Kentucky Research Foundation | Use of lobeline compounds in the treatment of central nervous system diseases and pathologies |
US5830904A (en) * | 1997-02-05 | 1998-11-03 | University Of Kentucky Research Foundation | Lobeline compounds as a treatment for psychostimulant abuse and withdrawal, and for eating disorders |
AUPO897997A0 (en) * | 1997-09-04 | 1997-09-25 | King, Michael Glenn | Improved compositions and methods for the control of smoking |
ES2141024B1 (es) * | 1997-10-03 | 2000-10-16 | Manzanares Jesus Mari Gonzalez | Preparado de accion antinicotinica. |
WO2000004882A1 (en) * | 1998-07-21 | 2000-02-03 | Alpenstock Holdings Limited | Formulations of anionic polysaccharides |
US6344222B1 (en) | 1998-09-03 | 2002-02-05 | Jsr Llc | Medicated chewing gum delivery system for nicotine |
US6358060B2 (en) | 1998-09-03 | 2002-03-19 | Jsr Llc | Two-stage transmucosal medicine delivery system for symptom relief |
US6531114B1 (en) | 1999-04-06 | 2003-03-11 | Wm. Wrigley Jr. Company | Sildenafil citrate chewing gum formulations and methods of using the same |
US7163705B2 (en) | 1998-12-15 | 2007-01-16 | Wm. Wrigley Jr. Company | Coated chewing gum product and method of making |
US6627234B1 (en) | 1998-12-15 | 2003-09-30 | Wm. Wrigley Jr. Company | Method of producing active agent coated chewing gum products |
US6586023B1 (en) | 1998-12-15 | 2003-07-01 | Wm. Wrigley Jr. Company | Process for controlling release of active agents from a chewing gum coating and product thereof |
US6322806B1 (en) | 1999-04-06 | 2001-11-27 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations including tableted center |
US7935362B2 (en) | 1999-04-06 | 2011-05-03 | Wm. Wrigley Jr. Company | Over-coated product including consumable center and medicament |
US6355265B1 (en) | 1999-04-06 | 2002-03-12 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
US6773716B2 (en) | 1999-04-06 | 2004-08-10 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
US6663849B1 (en) | 2000-09-01 | 2003-12-16 | Wm. Wrigley Jr. Company | Antacid chewing gum products coated with high viscosity materials |
US6569472B1 (en) | 2000-09-01 | 2003-05-27 | Wm. Wrigley Jr. Company | Coated chewing gum products containing antacid and method of making |
US6541048B2 (en) | 1999-09-02 | 2003-04-01 | Wm. Wrigley Jr. Company | Coated chewing gum products containing an acid blocker and process of preparing |
US6645535B2 (en) | 1999-09-02 | 2003-11-11 | Wm. Wrigley Jr. Company | Method of making coated chewing gum products containing various antacids |
US6582738B2 (en) | 1999-09-13 | 2003-06-24 | Deseret Laboratories, Inc. | Process for preparing chewing gum containing a nutritional supplement |
US6322828B1 (en) | 1999-09-13 | 2001-11-27 | Deseret Laboratories, Inc. | Process for manufacturing a pharmaceutical chewing gum |
WO2001021147A1 (en) | 1999-09-20 | 2001-03-29 | Mastercare | Diet and weight control gum and sucker |
US9387168B2 (en) | 1999-09-20 | 2016-07-12 | Jack Barreca | Chewing gum with tomatidine |
US9253991B2 (en) | 1999-09-20 | 2016-02-09 | Jack Barreca | Chewing gum with B vitamins |
WO2001089476A1 (en) * | 2000-05-19 | 2001-11-29 | Npd Llc | Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements |
US6534527B2 (en) | 2000-06-02 | 2003-03-18 | Phytos, Inc. | Edible herbal compositions for relieving nicotine craving |
US7115288B2 (en) | 2000-06-09 | 2006-10-03 | Wm. Wrigley Jr. Company | Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener |
US6572900B1 (en) | 2000-06-09 | 2003-06-03 | Wm. Wrigley, Jr. Company | Method for making coated chewing gum products including a high-intensity sweetener |
DE10037983B4 (de) * | 2000-08-03 | 2006-04-13 | Stefan Zikeli | Polymerzusammensetzung und daraus hergestellter Formkörper mit einem Gehalt an Alkaloid |
US6444241B1 (en) | 2000-08-30 | 2002-09-03 | Wm. Wrigley Jr. Company | Caffeine coated chewing gum product and process of making |
US6579545B2 (en) | 2000-12-22 | 2003-06-17 | Wm. Wrigley Jr. Company | Coated chewing gum products containing an antigas agent |
SE521512C2 (sv) | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
WO2004056363A2 (en) | 2002-12-20 | 2004-07-08 | Niconovum Ab | A physically and chemically stable nicotine-containing particulate material |
US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
WO2005046363A2 (en) | 2003-11-07 | 2005-05-26 | U.S. Smokeless Tobacco Company | Tobacco compositions |
US20050234024A1 (en) * | 2004-04-14 | 2005-10-20 | Clarke David E | Materials and methods for the treatment of ulcerative colitis |
US20060211649A1 (en) * | 2005-03-21 | 2006-09-21 | Eric Marchewitz | Use of cytisine for enhancing physical performance |
WO2007041035A2 (en) * | 2005-09-30 | 2007-04-12 | Wm. Wrigley Jr. Company | Oral composition and method for stress reduction associated with smoking cessation |
CA2646942C (en) | 2006-03-16 | 2014-07-29 | Niconovum Ab | Improved snuff composition |
US8642016B2 (en) | 2006-07-21 | 2014-02-04 | Jsrnti, Llc | Medicinal delivery system, and related methods |
US8506936B2 (en) * | 2008-11-25 | 2013-08-13 | Watson Laboratories, Inc. | Stabilized nicotine chewing gum |
CN106390128B (zh) | 2011-01-10 | 2022-07-08 | 伊沃恩有限公司 | β-肾上腺素能反向激动剂用于戒烟的用途 |
US20160199315A1 (en) * | 2013-08-23 | 2016-07-14 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch |
PL408608A1 (pl) | 2014-06-18 | 2015-12-21 | Pharmacia Polonica Spółka Z Ograniczoną Odpowiedzialnością | Trwała stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania |
EP3598968A1 (en) * | 2018-07-23 | 2020-01-29 | Adamed Pharma S.A. | Solid pharmaceutical cytisine composition |
CA3153405A1 (en) | 2019-09-12 | 2021-03-18 | Achieve Life Sciences, Inc. | Compositions comprising cytisine in the treatment and/or prevention of addiction in subjects in need thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL255047A (sv) * | 1959-08-21 | |||
FR4627M (sv) * | 1965-05-14 | 1966-11-28 | ||
NL167303C (nl) * | 1970-07-22 | Leo Ab | Vormstukken van kauwgom, bestaande uit een kauwgomba- sismassa, een tabaksalkaloide en eventueel andere ge- bruikelijke bestanddelen van kauwgom. | |
US3877468A (en) * | 1970-07-22 | 1975-04-15 | Leo Ab | Chewable tobacco substitute composition |
US3901248A (en) * | 1970-07-22 | 1975-08-26 | Leo Ab | Chewable smoking substitute composition |
US3818107A (en) * | 1972-09-28 | 1974-06-18 | Brook D | Chewing gum with sustained flavor release compositions |
JPS5716773B2 (sv) * | 1974-05-17 | 1982-04-07 | ||
CA1087905A (en) * | 1976-02-02 | 1980-10-21 | Donald A.M. Mackay | Long-lasting flavored chewing gum including chalk- free gum base |
US4151270A (en) * | 1977-09-26 | 1979-04-24 | Wm. Wrigley Jr. Company | Chewing gum composition |
US4195645A (en) * | 1978-03-13 | 1980-04-01 | Celanese Corporation | Tobacco-substitute smoking material |
US4276890A (en) * | 1979-04-11 | 1981-07-07 | Fichera Anthony T | Tobacco smoking inhibitor |
-
1983
- 1983-02-22 CH CH5780/83A patent/CH658594A5/de not_active IP Right Cessation
- 1983-02-22 GB GB08327748A patent/GB2125699B/en not_active Expired
- 1983-02-22 DE DE833332429T patent/DE3332429T1/de not_active Withdrawn
- 1983-02-22 WO PCT/SU1983/000004 patent/WO1983002892A1/en active Application Filing
- 1983-02-22 JP JP83501017A patent/JPS59500217A/ja active Pending
- 1983-10-07 SE SE8305535A patent/SE456135B/sv not_active IP Right Cessation
-
1987
- 1987-03-05 US US07/023,914 patent/US4971079A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE3332429T1 (de) | 1984-01-26 |
WO1983002892A1 (en) | 1983-09-01 |
SE456135B (sv) | 1988-09-12 |
SE8305535D0 (sv) | 1983-10-07 |
GB2125699A (en) | 1984-03-14 |
US4971079A (en) | 1990-11-20 |
CH658594A5 (de) | 1986-11-28 |
JPS59500217A (ja) | 1984-02-16 |
GB8327748D0 (en) | 1983-11-16 |
GB2125699B (en) | 1986-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8305535L (sv) | Lekemedelspreparat med antinikotinverkan och forfarande for framstellning derav | |
HUT58036A (en) | Process for producing new substituted aminomethyl tetraline derivatives and their heterocyclic analogs, as well as pharmaceutical compositions comprising such compounds | |
DE3775882D1 (de) | Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen. | |
MY103850A (en) | Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them. | |
OA06563A (fr) | Procédé de préparation de nouveaux dérivés d'indolizine. | |
FR2649110B1 (fr) | Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
ATE9472T1 (de) | Amino-desoxy-1.4; 3.6-dianhydro-hexit-nitrate, verfahren zu ihrer herstellung und pharmazeutische zubereitung. | |
DK232483A (da) | Fremgangsmaade til fremstilling af ws 6049-forbindelser | |
DE3773077D1 (de) | Immunotoxine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ATE37533T1 (de) | Derivate der 4-phenyl-4-oxo-buten-2-saeure, verfahren zu ihrer herstellung, medikamente und mischungen mit diesen derivaten. | |
DE3062340D1 (en) | 1-n-alkylsisomicin derivatives, process for their preparation and their use as medicines | |
ZA824118B (en) | Saturated aminocyclitol derivatives, their preparation and medicaments containing these compounds | |
DE3280245D1 (de) | Imidazolverbindungen, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen. | |
IL82925A0 (en) | Tetrahydrobenzothiazoles,their preparation and pharmaceutical compositions containing them | |
KR840002901A (ko) | 세라펩타제를 안정화 세라펩타제를 안정화 시키는 방법 | |
ES8301239A1 (es) | Procedimiento para la preparacion de nitratos de alquilami- nodesoxi-1.4,3.6-dianhidro-hexito sustituidos con bases pu- rinicas | |
PL287557A1 (en) | Method of obtaining 2-/pyridil-3/-tetrahydrothiopyranocarbothiamide | |
PT70107A (fr) | Procede de preparation de nouveaux derives de 1,3-benzoxazine-2,4-dione et des compositions pharmaceutiques les contenant | |
JPS51136783A (en) | Method for preparing a polymer containing a skelton of stabilizer in the molecule | |
FR2523964B1 (fr) | Nouveaux derives de la tryptamine actifs notamment sur le systeme cardiovasculaire et procede pour leur preparation | |
SE8305386D0 (sv) | 15-cycloaliphatic derivatives of 13,14-didehydro-carboprostacyclins and process for their preparation | |
BE882684A (fr) | Procede de preparation d'un vaccin antirabique et vaccin obtenu suivant ce procede | |
ES8401966A1 (es) | Procedimiento para preparar las (2,3-dihidro(1,4-benzodioxin-2-il) alcoil) piperidin-4-il-(n-ciano-n'-r) guanidinas. | |
BE894630A (fr) | Nouveaux derives de 20, 21-dinoreburnamenine eventuellement substitues sur le cycle e, procede et intermediaires de preparation, application comme medicament et compositions les renferment | |
ATE128977T1 (de) | 1,4-benzodioxanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 8305535-0 Effective date: 19940910 Format of ref document f/p: F |